These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32295687)

  • 41. Commonality between BCS and TCS.
    Shah VP; Rădulescu FŞ; Miron DS; Yacobi A
    Int J Pharm; 2016 Jul; 509(1-2):35-40. PubMed ID: 27208656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Provisional biopharmaceutical classification of some common herbs used in Western medicine.
    Waldmann S; Almukainzi M; Bou-Chacra NA; Amidon GL; Lee BJ; Feng J; Kanfer I; Zuo JZ; Wei H; Bolger MB; Löbenberg R
    Mol Pharm; 2012 Apr; 9(4):815-22. PubMed ID: 22352942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls.
    Papich MG; Martinez MN
    AAPS J; 2015 Jul; 17(4):948-64. PubMed ID: 25916691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of dissolution profiles for sustained release resinates of BCS class I drugs using USP apparatus 2 and 4: a technical note.
    Prabhu NB; Marathe AS; Jain S; Singh PP; Sawant K; Rao L; Amin PD
    AAPS PharmSciTech; 2008; 9(3):769-73. PubMed ID: 18563575
    [No Abstract]   [Full Text] [Related]  

  • 45. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan.
    Takagi T; Ramachandran C; Bermejo M; Yamashita S; Yu LX; Amidon GL
    Mol Pharm; 2006; 3(6):631-43. PubMed ID: 17140251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.
    Wu CY; Benet LZ
    Pharm Res; 2005 Jan; 22(1):11-23. PubMed ID: 15771225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The utility of rat jejunal permeability for biopharmaceutics classification system.
    Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Islambulchilar Z
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1496-502. PubMed ID: 19929209
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio.
    Rinaki E; Valsami G; Macheras P
    Pharm Res; 2003 Dec; 20(12):1917-25. PubMed ID: 14725354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physicochemical profiling (solubility, permeability and charge state).
    Avdeef A
    Curr Top Med Chem; 2001 Sep; 1(4):277-351. PubMed ID: 11899112
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leveraging BCS in Development: A Case Study.
    Hoaglund Hyzer CS; Fadda HM; Rodriguez JO; Aburub A
    Mol Pharm; 2015 Oct; 12(10):3685-90. PubMed ID: 26365521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension.
    Lennernäs H; Abrahamsson B
    J Pharm Pharmacol; 2005 Mar; 57(3):273-85. PubMed ID: 15807982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biopharmaceutics classification system: validation and learnings of an in vitro permeability assay.
    Thiel-Demby VE; Humphreys JE; St John Williams LA; Ellens HM; Shah N; Ayrton AD; Polli JW
    Mol Pharm; 2009; 6(1):11-8. PubMed ID: 19248229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
    Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
    Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Predictions by BCS, rDCS and Machine Learning for the Effect of Food on Oral Drug Absorption Based on Features Calculated In silico.
    Hoshino Y; Yoshioka H; Hisaka A
    AAPS J; 2021 Dec; 24(1):10. PubMed ID: 34893922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Paediatric biopharmaceutics classification system: current status and future decisions.
    Batchelor H;
    Int J Pharm; 2014 Aug; 469(2):251-3. PubMed ID: 24602991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico, in vitro, and preclinical in vivo data.
    Heimbach T; Xia B; Lin TH; He H
    AAPS J; 2013 Jan; 15(1):143-58. PubMed ID: 23139017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Matrix effects of the hydroethanolic extract and the butanol fraction of calyces from Physalis peruviana L. on the biopharmaceutics classification of rutin.
    Domínguez Moré GP; Feltrin C; Brambila PF; Cardona MI; Echeverry SM; Simões CMO; Aragón DM
    J Pharm Pharmacol; 2020 May; 72(5):738-747. PubMed ID: 32162346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: Part II. Non-linear kinetics.
    Fernández-Teruel C; Gonzalez-Alvarez I; Navarro-Fontestad C; García-Arieta A; Bermejo M; Casabó VG
    Eur J Pharm Sci; 2009 Jan; 36(1):147-56. PubMed ID: 19038335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of the biopharmaceutical classification system in clinical drug development--an industrial view.
    Cook J; Addicks W; Wu YH
    AAPS J; 2008 Jun; 10(2):306-10. PubMed ID: 18500563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ICH M9 Guideline in Development on Biopharmaceutics Classification System-Based Biowaivers: An Industrial Perspective from the IQ Consortium.
    Bransford P; Cook J; Gupta M; Haertter S; He H; Ju R; Kanodia J; Lennernäs H; Lindley D; Polli JE; Wenning L; Wu Y
    Mol Pharm; 2020 Feb; 17(2):361-372. PubMed ID: 31846335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.